5 takeaways from the Supreme Court ruling on gender-affirming care
Briefly

5 takeaways from the Supreme Court ruling on gender-affirming care
"Chief Justice John Roberts, in his majority opinion, noted that studies in some European countries have raised questions about the effects of gender-affirming care, contending that treatments such as hormone therapy and puberty blockers are risky."
"Justice Clarence Thomas also wrote a concurring opinion questioning the scientific case for gender-affirming care, asserting that the claims of overwhelming evidence supporting the use of puberty blockers and cross-sex hormones are untenable."
The U.S. Supreme Court ruled 6-3 to uphold Tennessee's ban on gender-affirming care for transgender minors in the case U.S. v. Skrmetti. This decision, seen as devastating by LGBTQ+ advocates, claims the ban does not discriminate based on gender identity. Majority opinions expressed concerns over the risks associated with gender-affirming treatments. The ruling means affected minors and their families may have to seek care out-of-state, raising significant concerns about the health and well-being of transgender youth in states with such bans.
Read at Advocate.com
Unable to calculate read time
[
|
]